IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
IOBT is expected to report earnings to rise 8.82% to -37 cents per share on August 08
Q2'25
Est.
$-0.37
Q1'25
Missed
by $0.03
Q4'24
Missed
by $0.17
Q3'24
Missed
by $0.07
Q2'24
Beat
by $0.03
The last earnings report on May 14 showed earnings per share of -34 cents, missing the estimate of -31 cents. With 281.07K shares outstanding, the current market capitalization sits at 73.13M.